trial
as of 2026-07-01Pharmacokinetics and Safety Studies of Esomeprazole Use in Schizophrenia Patients
NCTId NCT03333603
at a glance
Phase 4 · Completed
Enrollment 25 (actual)
Sponsored by National Taiwan University Hospital
Primary completion 2017-01-23
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 4
Status
Completed
Enrollment
25 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2016-05-23
Primary completion
2017-01-23
Eligibility
ALL · 20 Years · 65 Years
Interventions & indications
Drugs
Indications
Sponsors
National Taiwan University HospitalLead Sponsor
National Taiwan University HospitalCollaborator
Investigators
1
Chih-Min LiuPrincipal Investigator
Sites
2 total
Taipei, TaiwanTaipei, Taiwan
Facts & assertions
4 sourced
Enrollment
25
Phase
PHASE4
Primary Completion Date
2017-01-23
Status
COMPLETED
relationships
The graph out of here
drug
drug
lead_sponsor
collaborator
indication
indication
indication
investigator
person